Lincoln Pharmaceuticals Ltd.
| BSE: 531633 | Sector: Health care |
| NSE: LINCOLN | ISIN Code: INE405C01035 |
| BSE 00:00 | 24 Jun | 283.25 |
0.65 (0.23%) |
OPEN
284.90 |
HIGH
285.60 |
LOW
282.55 |
| NSE 00:00 | 24 Jun | 283.00 |
0.15 (0.05%) |
OPEN
287.90 |
HIGH
287.90 |
LOW
282.10 |
| OPEN | 284.90 |
| PREVIOUS CLOSE | 282.60 |
| VOLUME | 14418 |
| 52-Week high | 414.75 |
| 52-Week low | 255.00 |
| P/E | 8.18 |
| Mkt Cap.(Rs cr) | 567 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lincoln Pharmaceuticals Ltd. (LINCOLN) - Announcements
-
Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
15/06/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
15/06/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
10/06/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
10/06/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
07/06/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
03/06/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Regulation 23(9)-Disclosure Of Related Party Transactions
02/06/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
27/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
27/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
20/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
20/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Financial Result For The Quarter And Year Ended March 31 2022
19/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Board recommends Dividend
19/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of The Board Meeting
19/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Board to consider Dividend
11/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Board Meeting Intimation for Inter-Alia To Consider And Approve The Audited (Standalone And Consolid
11/05/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
25/04/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Certificate Under Regulation 40 (9) Of The SEBI (Listing Obligations And Disclosure Requirements) Re
25/04/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Compliance Certificate Under Regulation 7 (3) Of SEBI (LODR) For The Period Ended March 31 2022
12/04/2022 | bse |
Downlaod PDF -
Lincoln Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
11/04/2022 | bse |
Downlaod PDF
Quick Links for Lincoln Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
